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Abstract
New neurons are added on a daily basis to the olfactory bulb (OB) of a mammal, and this phenomenon exists throughout its lifetime.
These new cells are born in the subventricular zone and migrate to the OB via the rostral migratory stream (RMS). To examine the
role of the prokineticin receptor 2 (Prokr2) in neurogenesis, we created a Prokr2 null mouse, and report a decrease in the volume of
its OB and also a decrease in the number of bromodeoxyuridine (BrdU)-positive cells. There is disrupted architecture of the OB, with
the glomerular layer containing terminal dUTP nick-end labeling (TUNEL) -positive nuclei and also a decrease in tyrosine
hydroxylase-positive neurons in this layer. In addition, there are increased numbers of doublecortin-positive neuroblasts in the RMS
and increased PSA-NCAM (polysialylated form of the neural cell adhesion molecule) -positive neuronal progenitors around the
olfactory ventricle, indicating their detachment from homotypic chains is compromised. Finally, in support of this, Prokr2-deﬁcient
cells expanded in vitro as neurospheres are incapable of migrating towards a source of recombinant human prokineticin 2 (PROK2).
Together, these ﬁndings suggest an important role for Prokr2 in OB neurogenesis.
Introduction
It is well established that there are two main areas where neurogenesis
occurs in the adult mammalian brain, the dentate gyrus of the
hippocampus and the olfactory bulb (OB; for reviews, see Gould
et al., 1999; Alvarez-Buylla & Garcia-Verdugo, 2002; Watts et al.,
2005). In the murine brain, the OB granular and periglomerular layers
are supplied with new interneurons originating in the lateral wall of the
subventricular zone (SVZ), which migrate there via the rostral
migratory stream (RMS; Kaplan & Hinds, 1977; Luskin, 1993).
The prokineticins (Prok1 and Prok2) are two recently identiﬁed
secreted bioactive molecules (Li et al., 2001; LeCouter et al., 2003).
Signal transduction of both molecules is via two closely related G-
protein-coupled receptors (Prokr1 and Prokr2; Lin et al., 2002; Masuda
et al., 2002; Soga et al., 2002). To date several physiological roles have
been attributed to the prokineticins and their receptors: most notably
gut motility (Li et al., 2001), reproductive function (Matsumoto et al.,
2006; Maldonado-Perez et al., 2007) and circadian output from the
suprachiasmatic nuclei (Cheng et al., 2002; Li et al., 2006; Prosser
et al., 2007). Expression analysis has revealed spatially distinct and
overlapping areas of expression of prokineticins and their receptors (Li
et al., 2001; Cheng et al., 2002; Lin et al., 2002; Masuda et al., 2002;
Ng et al., 2005; Matsumoto et al., 2006). Of particular relevance to this
study, Prokr2 and Prokr1 expression has been detected by in situ
hybridization in the SVZ, RMS, olfactory ventricle ependyma and
subependymal layers, while Prok2, but not Prok1, is expressed in the
OB granular and perigranular layers (Ng et al., 2005; Matsumoto et al.,
2006). More recently, the expression of both prokineticins and their
receptors have been mapped by in situ hybridization in the adult mouse
brain, demonstrating that Prok2 and Prokr2 are more widely expressed
in the brain than Prok1 and Prokr1 (Cheng et al., 2006).
In this study we have generated a null mutant mouse line for Prokr2
(Prosser et al., 2007) that shows abnormal development of the OB in
accordance with that previously described for the Prokr2 (Matsumoto
et al., 2006) and Prok2 knockouts (Ng et al., 2005). We describe the
ﬁne-scale OB structural deformities in Prokr2 null mice, and the effect
on neuroblast migration from the SVZ to the OB. In addition, we
describe aroleforProkr2inchemoattraction withintheOBandinvitro.
Materials and methods
Gene knockout
The prokr2
Brdm1 allele (abbreviated here to m) was conﬁrmed by
radio-ligand binding assay to be a functional null (Prosser et al.,
2007). The mice were of mixed 129:C57B⁄6 genetic background, and
were F1 or F2 intercrosses of mice backcrossed four–six times to the
C57B⁄6 genetic background. All studies were licensed by the UK
Home Ofﬁce under the Animals (Scientiﬁc Procedures) Act 1986.
Bromodeoxyuridine (BrdU) administration
Mice either received BrdU (300 mg⁄kg i.p.) as a single injection at
6 weeksofageandwereperfused(4%paraformaldehyde)21 dayslater
(genotypes: 7 m⁄m,1 0+⁄m,6+⁄+), or received ﬁve daily injections of
BrdU (50 mg⁄kg) and then perfused 1 day later (genotypes: 8 m⁄m,7
+⁄m,7+⁄+), or received a single injection of BrdU (100 mg⁄kg) and
perfused 2 h later (genotypes: 3 m⁄m,4+⁄m,3+⁄+). Mice were given
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postﬁxed overnight and equilibrated in 30% sucrose.
Immunohistochemistry
A 1 : 6 series of free-ﬂoating sections (40 lm) was immunostained
as follows: sheep anti-BrdU (1 : 3000; Fitzgerald), mouse anti-
tyrosine hydroxylase (TH; 1 : 500; Chemicon), goat anti-doublecor-
tin (DCX; 1 : 400; Santa Cruz), rabbit anti-calbindin (1 : 500;
Sigma) and the polysialylated form of the neural cell adhesion
molecule (PSA-NCAM) (1 : 500; Chemicon). For diaminobenzidine
(DAB) staining sections were treated with 10% hydrogen peroxide in
10% methanol (5 min), 2 N HCl at 37  C (20 min), borate buffer
(2 · 10 min), Tris-buffered saline (TBS) containing 0.2% Triton and
5% normal donkey serum (NDS; 2 h). Anti-sheep BrdU incubation
was overnight at 4  C followed by three · TBS washes. Secondary
antibody [anti-sheep biotin (1 : 400) 2 h], followed by three · TBS
washes and avidin-biotin complex (Vectastain ABC kit, Vector
Laboratories) in TBS (2 h). Antigens were visualized using DAB.
For TH, calbindin and DCX staining the HCl step was omitted and a
secondary antibody against mouse, rabbit or goat, respectively, was
used. For immunoﬂuorescent staining the quenching and avidin-
biotin complex steps were omitted. Anti-mouse IgM-biotin was used
for PSA NCAM. The tertiary antibody used was strepavidin-Alexa-
568. Hoescht was included in ﬁnal antibody incubations as a nuclear
stain. Terminal dUTP nick-end labeling (TUNEL) staining was
carried out on 40-lm brain sections using Manufacturer’s instruc-
tions (Roche).
Transwell assay
SVZ was excised from N6F2 generation P0 pups under sterile
conditions. Following accutase (Sigma) treatment (10 min) and
three · washes with Dulbecoo’s modiﬁed essential medium
(DMEM)⁄B27 (2%), cells were triturated. Viable cells were counted
and seeded at 200 K⁄mL in DMEM⁄HAMS F12 (3 : 1), B27 (2%),
100 units penicillin⁄100 mg streptomycin⁄0.25 mg amphotericin,
ﬁbroblast growth factor (FGF)-2 (20 ng⁄mL), epidermal growth
factor (EGF; 20 ng⁄mL) and heparin (5 lg⁄mL). After 4 days, cells
dissociated with accutase were plated at 25 K⁄mL onto the upper
chamber of an 8-lm transwell (ChemoTx, Neuro Probe) previously
coated with ﬁbronectin (1 lg⁄mL). Lower chamber media was plus or
minus recombinant PROK2 (30 ng⁄mL). After 24 h cells in the lower
chamber were counted. The experiment was repeated on four
occasions. The neural progenitor cells (NPCs) from three different
mice of each genotype were used on each occasion, and the
experiment on cells from each mouse was repeated three times.
Quantiﬁcation and statistical analysis
BrdU-positive cells were counted (double-blinded) and scored using
Olympus CAST-Grid stereology and Fractionator method. Statistical
signiﬁcance was determined by one-way anova⁄Neumann–Kuels
post hoc test.
Results
OBs of prokr2
Brdm1 homozygous mice are smaller
and disorganized
The generation of the prokr2
Brdm1 (abbreviated here to m) allele has
been described elsewhere (Prosser et al., 2007). Anatomical analysis
of the brain demonstrated that the sizes of the right and left OB were
symmetrically reduced in m⁄m mice (n ¼ 7) when compared with
their +⁄+ littermate controls (n ¼ 6; Fig. 1A–D) and +⁄m controls
(n ¼ 7; data not shown). In addition, the normal morphology of the
OB was distorted, in that there was a distinct absence of the
glomerular layer (GL), mitral cell layer and internal plexiform layer
in m⁄m mice (Fig. 1E and F). Volumetric analysis of the m⁄m OB
demonstrated that they are four times smaller than those of either
+⁄+o r+⁄m littermates (Fig. 1D). In addition, the width of the OB
was narrower in m⁄m mice than either their +⁄+o r+⁄m littermates
(+⁄+ 870 + 33; +⁄m 880 + 40; m⁄m 395 + 20 lm). In order to
determine if ongoing cell death contributes to the OB defect of the
m⁄m mice, TUNEL staining was performed that revealed this was
indeed the case (Fig. 2A–C). Interestingly, TUNEL-positive nuclei
were most pronounced in the area that should constitute the missing
GL (Fig. 2C). There was no difference in TUNEL-positive staining
between m⁄m and control mice elsewhere in the brain (data not
shown).
Newborn prokr2
Brdm1 homozygous C57BL⁄6 inbred mice
suckle effectively
As previously documented, the m⁄m mice exhibit partially penetrant
postnatal lethality during the ﬁrst few days after birth (Prosser et al.,
2007). The penetrance of the lethality was very severe upon backcross
to the C57BL⁄6 genetic background. Despite this, P0 m⁄m mice of
the N8 C57BL⁄6 backcross generation showed an obvious milk band
comparable in volume to their +⁄m and +⁄+ littermates (Supplemen-
tary material, Fig. S1). Therefore, deﬁciency in the ability to suckle
and compete with littermates is not apparent during the ﬁrst day after
birth.
Exclusive loss of NPCs in the OB of Prokr2 null mice
In order to determine if the difference in OB size might be accounted
for by a difference in the numbers of dividing progenitors, BrdU
incorporation was counted 3 weeks after a single BrdU injection.
Results demonstrate that there was indeed about a threefold decrease
in the OB BrdU-positive cells of m⁄m mice compared with +⁄m or
+⁄+ littermates (Fig. 2D–F). In addition, short-term BrdU experiments
where animals were killed 24 h after ﬁve daily BrdU injections also
showed a decrease in labelling in the OB in m⁄m mice (+⁄+
102 071.5 ± 5499; m⁄m 25 283 ± 1649; +⁄m 98 989 ± 9336). How-
ever, there was no difference in cell numbers in the SVZ (+⁄+
1844 ± 652; m⁄m 1572 ± 363; +⁄m 1765 ± 412), indicating that cell
proliferation is not defective but their arrival to the OB is impeded.
The BrdU-positive cells are being delayed in the RMS (data not
shown).
In order to determine that the lack of difference in SVZ proliferation
might be due to a survival effect over the 5 days of BrdU
administration, we gave a single injection of BrdU and killed
the animals 2 h later. Results show that there was no difference in
the number of BrdU-positive cells in the SVZ at this time
(+⁄+ 1903 + 261; m⁄m 1750.61 + 259; +⁄m 1560.05 + 213), again
indicating that cell proliferation is not defective.
We next examined if proliferation in another neurogenic region, the
dentate gyrus, was affected. Results demonstrate that there was no
difference in proliferation between m⁄m and +⁄+o r+⁄m mice in this
region (+⁄+ 1003 ± 344; m⁄m 1237 ± 39; +⁄m 1168 ± 165). In all
cases the counts for BrdU-positive cells were not signiﬁcantly
different between +⁄m and +⁄+ mice.
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European Journal of Neuroscience, 26, 3339–3344Fig. 2. TUNEL staining and cell proliferation in the OB. (A) + ⁄ + OB showing lack of TUNEL staining compared with (B) TUNEL-positive staining in the
m ⁄ m mice shown in higher-power magniﬁcation in (C). Note, staining is highest in the GL where architecture is distorted (see also Fig. 1). (D) There is a decrease
in bromodeoxyuridine (BrdU) staining in the OB of m ⁄ m mice compared with + ⁄ +o r+⁄ m 21 days after a single injection of BrdU (***P<0.001 versus + ⁄ +,
+ ⁄ m; n ¼ 6). (E) BrdU staining of OB in + ⁄ + mice (magniﬁcation 5 ·). The boxed region in (E) is shown in the corner of (E). (F) BrdU staining in OB of m ⁄ m
mice (magniﬁcation 5 ·), the boxed region in (F) is shown in the corner of (F). Note, the difference in size of the OB at 5 · magniﬁcation. Scale bars: 100 lm (A and
B); 20 lm (C); 500 lm (E and F).
Fig. 1. Analysis of OBs. Macro- and microscopic analysis of OB from m ⁄ m and + ⁄ + mice. (A) Macroscopic view of a m ⁄ m mouse compared with a + ⁄ +
littermate at 9 weeks old. (B) + ⁄ + OB showing normal size of OB. (C) m ⁄ m OB showing decreased size compared with + ⁄ +. (D) m ⁄ m show decreased volume
of the OB compared with either + ⁄ +o r+⁄ m (***P<0.001 versus + ⁄ +, + ⁄ m; n ¼ 6). (E) Boxed region in (B) and (F), boxed region in (C), comparison of
architecture of OB in (B), + ⁄ + vs (C), m ⁄ m mice. There is a decrease in the overall size of the OB, which can be contributed to a complete absence of a discernable
olfactory nerve layer (ONL), glomerular layer (GL), mitral cell layer (MCL) and internal plexiform layer (IPL). There is evidence of the external plexiform layer
(EPL) in the homozygous and also the granule cell layer (GRL). Scale bars: 1 mm (B and C); 200 lm (D and E). Arrows in (E) and (F) indicate that the GRL extends
beyond the edge of the ﬁgure.
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Given that there is abnormal architecture of the OB, we next
determined if genesis of dopaminergic neurons was affected. TH is a
marker for dopaminergic neurons normally present within the GL of
the OB. We report here that the number of dopaminergic neurons in
this region is decreased in m⁄m mice (Fig. 3A and B). Further
examination of the OB revealed that calbindin-positive neurons were
found predominately in the GL of the +⁄+ mice. In contrast, this
population of neurons was dispersed throughout the OB of the m⁄m
mice, indicating that their differentiation in their ﬁnal destination (GL)
is impeded (supplementary Fig. S2). Examination of the RMS
revealed that there was an increase in newborn neurons that express
DCX in m⁄m mice (Fig. 3C and D). DCX-positive neurons occupied
8.34 ± 1.19% of the area of the RMS in m⁄m mice, whereas they
occupied 1.29 ± 0.25% in +⁄+ mice, signifying a defect in their
ability to reach the OB in m⁄m mice. In addition, PSA-NCAM-
labelled neuronal progenitors are increased in the olfactory ventricle of
m⁄m mice with progenitors appearing in tighter clusters relative to
control mice, indicating a failure in disassociation from their
homotypic chains (Fig. 3E–H).
SVZ progenitors of Prokr2 null mice lose their ability
to migrate towards its ligand
In order to determine the effect of PROKR2 loss upon Prok2
chemoattraction for SVZ progenitor cells, we used a transwell assay.
NPCs derived from +⁄+, +⁄m and m⁄m mice at P0 were expanded in
EGF and FGF2 for 4 days, at the end of which they were dissociated
to a single cell suspension and plated in the upper chamber. They were
allowed to migrate through the membrane ﬁlter separating the upper
and lower chambers towards a source of recombinant Prok2. Results
show that m⁄m cells had a decreased ability to migrate compared with
either +⁄+o r+⁄m cells (Fig. 4). The migration of m⁄m cells was not
signiﬁcantly different from that of the negative control, namely
treatment of +⁄+ cells with media containing no PROK2 (Fig. 4).
Discussion
The persistence of new neuronal production within the OB throughout
the lifetime of an animal suggests this process has a fundamental
biological signiﬁcance. This study has directly addressed the impor-
tance of Prokr2 signalling in this process, by generating a null
mutation. One of the most striking effects in the CNS of the Prokr2
null mice was a marked decrease in the size of the OB, as has been
previously described (Matsumoto et al., 2006). In addition, the
layering of the OB was abnormal, the six well-described layers: nerve,
glomerular, external plexiform, mitral, internal plexiform and granular
were not all present. In fact, the glomerular, mitral and internal
plexiform layers were all anatomically indiscernible. In addition to
distorted morphology, there is also a signiﬁcant decrease in the A16
group of dopamine neurons in Prokr2 null mice, as evidenced by a
signiﬁcant reduction in TH-positive neurons in the periglomerular
layer. Indeed, it has previously been shown that TH is not expressed
on these cells until they reach their ﬁnal destination (McLean &
Shipley, 1988). Interestingly, the location of another population of
Fig. 4. Transwell assay. There is a decrease in migration of cells grown from
m ⁄ m mice towards the Prokr2 receptor ligand PROK2 compared with + ⁄ +o r
+ ⁄ m littermates (*P<0.05 versus Control + m ⁄ m,+ ⁄ m). Control wells
contained no PROK2 and demonstrated limited migration over the 24-h period.
Fig. 3. Neuronal differentiation in olfactory bulb (OB) and RMS. (A) Tyro-
sine hydroxylase (TH) staining in the GL of the + ⁄ + OB. (B) There is severe
depletion of TH in the OB GL of m ⁄ m mice compared with either + ⁄ +o r+⁄ –
(**P<0.01 versus + ⁄ +, + ⁄ m; n ¼ 5). (C) DCX-positive neurons in the
RMS of + ⁄ +. (C¢)2 0· magniﬁcation. (D) DCX-positive neurons in the RMS
of a m ⁄ m mouse. (D¢)2 0· magniﬁcation. Note the greater number of DCX-
positive neurons in the RMS of m ⁄ m mice, indicating their retention there
compared with + ⁄ +. (E) PSA-NCAM staining in the olfactory ventricle of
+ ⁄ +, compared with (F), m ⁄ m mouse. (G) Higher magniﬁcation (20 ·)o f
(E), (H) higher magniﬁcation (20 ·) of (F), demonstrating that PSA-NCAM
appears to be in tighter bundles in the m ⁄ m compared with + ⁄ + littermates.
Scale bars: 10 lm (A); 1 mm (C and D); 250 lm (E and F); 125 lm (G and H).
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GL, with a smaller proportion in the granule cell layer (Hwang et al.,
2002) was distorted in the Prokr2 null mice. In these mice the neurons
appeared relatively immature and were found throughout the OB and
not concentrated in the GL as in their wild-type littermates. Therefore,
their reduced numbers may be due to fewer reaching their ﬁnal
destination, combined with evidence of TUNEL-positive apoptotic
nuclei in the vicinity of this distorted layer. It is plausible that both
phenomena contribute to a reduction in these interneurons in this
region. Indeed, Prok2 has been shown to protect cells derived from the
corpus luteum against apoptotic cell death due to serum starvation
(Kisliouk et al., 2005).
A marked deﬁciency in OB development has previously been
reported in the Prokr2 null mice as early as E16.5 (Matsumoto et al.,
2006) and P1 (M.A.C., unpublished observations), suggesting that
Prokr2 is critical for the normal development of the OB. It is of interest
that in Prok2 knockout mice asymmetric OB malformation was
reported in approximately 50% of the mice (Ng et al., 2005), whereas
we and others (Matsumoto et al., 2006) found symmetrical OB
malformation in all of our Prokr2 null mice. Moreover, the degree of
organization in the OB of Prok2 null mice appears to vary with the
mitral cell layers being discernable in some but absent from other OB
lobes (Ng et al., 2005; Zhang et al., 2007) These observations suggest
that the Prokr2 null OB phenotype is more extensive than that for its
ligand Prok2 and conﬁrms the critical role of this receptor for OB
neurogenesis. In contrast, the more organized structures of the OB in
Prok2 nulls suggest that loss of the ligand can be partially compensated
by alternative mechanisms. However, the lack of Prok1 mRNA
expression detected in the OB (Cheng et al., 2006) raises doubt over
whether it can functionally substitute for Prok2 in the null mutant.
Tbrain-1 (Tbr-1) and the lysophosphatidic acid receptor (LpA1) null
mutant phenotypes, although mechanistically different, do share some
of the features of defective OB with the Prokr2 phenotype described
here. Null mutants for the Brachyuri homologue Tbr-1 are deﬁcient in
OB mitral and tufted cells (Bulfone et al., 1998), whereas the LpA1
null mice exhibit a probable deﬁcit in neuronal progenitor proliferation
and a partially penetrant reduction in OB wall thickness (Contos et al.,
2000). It is of interest that null mutants for Tbr-1 and LpA1 with
deformed OB are deﬁcient in suckling ability contributing to postnatal
lethality. Similarly, the Prok2 and Prokr2 nulls exhibit partial penetrant
lethality that might be caused by olfactory deﬁcits compromising
suckling (Li et al., 2006; Matsumoto et al., 2006; Prosser et al., 2007).
However, even in C57BL⁄6 backcrossed mice where the penetrance
of postnatal lethality is almost complete, Prokr2 null mice do have
milk in their stomachs. This suggests that olfactory impairment of
suckling ability is unlikely to be the critical factor in Prokr2 null
postnatal lethality.
Cell division in the SVZ is responsible for new neurons being added
to the granular and the periglomerular layers of the OB. These cells
migrate through the RMS, where the majority disperse throughout the
granule layer and a small percentage develop into interneurons in the
periglomerular layer. However, in the Prokr2 null mice the volume of
the OB is approximately fourfold less than wild-type littermates, and
the cell numbers reaching the OB are reduced by about threefold. This
is not due to a decrease in cell division in the SVZ as no deﬁciency
was noted in Prokr2 nulls. Instead it is their migration that is
compromised as they are being retained within the RMS and fail to
migrate from there out into the granular layer of the OB. This results in
a deﬁcit in differentiated granule cells and is likely to be responsible
for the marked reduction in the size of the OB and its distorted
architecture. This would suggest that the lack of Prokr2 might abolish
Prok2 signalling, which acts as a detachment signal for chain
migrating progenitors arriving from the RMS (Ng et al., 2005).
Further support for this comes from the increased accumulation and
tighter clustering of PSA-NCAM-positive neuronal progenitors
around the olfactory ventricle of Prokr2 null mice relative to wild-
type controls. In addition, DCX-positive neuronal progenitors accu-
mulated in the RMS, representing a higher percentage of cells than in
wild-type littermates. The evidence we present here that Prokr2
activation is essential for the migration and differentiation of neuronal
progenitors is similar to the OB phenotype of Mash1 null mutants
(Murray et al., 2003). Interestingly, it has recently been reported that
the expression of Mash1 and neurogenin1 (Ngn1) overlap with Prok2
in several neuronal populations of the OB, and that Prok2 is decreased
by 70% in Ngn1 null mice at P0 and 50% in Mash1 null mice at E16.5
compared with their respective wild-type littermates (Zhang et al.,
2007). In addition, both of these basic-helix-loop-helix transcription
factors are proposed to regulate Prok2 expression, and ChiP assays
have shown binding to the Prok2 promoter E-box motifs (Zhang et al.,
2007). This would suggest that Prok2 may mediate a functional role
for both Mash1 and Ngn1 in OB neurogenesis.
Quantitative evidence for the critical role of Prokr2 and the lack of
redundancy in the prokineticin receptors in mediating chemoattraction
by prokineticins was provided by transwell migration experiments
where SVZ cells from Prokr2 null mice demonstrated insigniﬁcant
PROK2-dependent migration relative to wild-type explants in the
absence of chemoattractant. This supports the morphological exam-
ination of Matsumoto et al. (2006) showing that exclusively Prokr2
and not Prokr1 knockouts display an OB phenotype.
The phenotypes of Prokr2 and Prok2 knockout mice model aspects
of human Kallman syndrome (KS), a partially penetrant genetic
disease that causes OB deformity and consequently anosomia and
hypogonadism with associated sterility and failure to reach puberty
(Ng et al., 2005; Matsumoto et al., 2006). It is likely that the
reproductive disorders are caused primarily by the absence of neurons
producing gonadotrophin-releasing hormone (Schwanzel-Fukuda
et al., 1989), as is the case in the Prokr2 null mouse (Matsumoto
et al., 2006). Approximately 20% of KS cases are caused by loss of
function mutations in either the X-linked KAL1 gene, that encodes
anosmin-1, or the ﬁbroblast growth factor receptor 1 gene (FGFR1),
responsible for an autosomal dominant form of the disease. It was
recently established that mutations within PROK2 (heterozygous) and
PROKR2 (homozygous, heterozygous or compound heterozygous) are
present within 10% of a cohort of patients with KS (Dode et al., 2006).
Thus, a deﬁciency in PROKR2 signalling is a likely cause of KS in
some patients. The presence of heterozygous mutations within the
PROKR2 and PROK2 genes of patients with KS suggests that either
partial PROKR2 signalling impairment is sufﬁcient to cause the KS on
its own or that inheritance of the disorder is dependent upon mutations
in additional genes involved in the same, or convergent, signalling
pathways (Dode et al., 2006).
In conclusion, we show that normal functioning of Prokr2 is
necessary for the migration of homotypic chains of neuroblasts through
the RMS and their detachment prior to their arrival at their ﬁnal
destination in either the granule or GL of the OB. Through this
mechanism this G-protein-coupled receptor is crucial for establishment
of the normal layered structure and ongoing neurogenesis of the OB.
Supplementary material
The following supplementary material may be found on http://
www.blackwell-synergy.com
Fig. S1. Prokr2 m⁄m mice are able to suckle milk.
Fig. S2. Calbindin-positive neurons in the OB.
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